Adeleine P - Search Results

1

Treatment of cerebellar ataxia with buspirone: a double-blind study.

Trouillas P, Xie J, Adeleine P. Trouillas P, et al. Among authors: adeleine p. Lancet. 1996 Sep 14;348(9029):759. doi: 10.1016/S0140-6736(05)65674-7. Lancet. 1996. PMID: 8806320 Clinical Trial. No abstract available.

2

Buspirone, a 5-hydroxytryptamine1A agonist, is active in cerebellar ataxia. Results of a double-blind drug placebo study in patients with cerebellar cortical atrophy.

Trouillas P, Xie J, Adeleine P, Michel D, Vighetto A, Honnorat J, Dumas R, Nighoghossian N, Laurent B. Trouillas P, et al. Among authors: adeleine p. Arch Neurol. 1997 Jun;54(6):749-52. doi: 10.1001/archneur.1997.00550180059013. Arch Neurol. 1997. PMID: 9193210 Clinical Trial.

3

[Effect of buspirone, a serotonergic 5-HT-1A agonist in cerebellar ataxia: a pilot study. Preliminary communication].

Trouillas P, Xie J, Getenet JC, Adeleine P, Nighoghossian N, Honnorat J, Riche G, Derex L. Trouillas P, et al. Among authors: adeleine p. Rev Neurol (Paris). 1995 Dec;151(12):708-13. Rev Neurol (Paris). 1995. PMID: 8787101 French.

4

Improvement of cerebellar ataxia with levorotatory form of 5-hydroxytryptophan. A double-blind study with quantified data processing.

Trouillas P, Brudon F, Adeleine P. Trouillas P, et al. Among authors: adeleine p. Arch Neurol. 1988 Nov;45(11):1217-22. doi: 10.1001/archneur.1988.00520350055016. Arch Neurol. 1988. PMID: 3190503 Clinical Trial.

5

Buspirone, a serotonergic 5-HT1A agonist, is active in cerebellar ataxia. A new fact in favor of the serotonergic theory of ataxia.

Trouillas P, Xie J, Adeleine P. Trouillas P, et al. Among authors: adeleine p. Prog Brain Res. 1997;114:589-99. doi: 10.1016/s0079-6123(08)63389-0. Prog Brain Res. 1997. PMID: 9193169 Clinical Trial.

6

Hyperbaric oxygen in the treatment of acute ischemic stroke. A double-blind pilot study.

Nighoghossian N, Trouillas P, Adeleine P, Salord F. Nighoghossian N, et al. Among authors: adeleine p. Stroke. 1995 Aug;26(8):1369-72. doi: 10.1161/01.str.26.8.1369. Stroke. 1995. PMID: 7631339 Clinical Trial.

7

Amantadine triple therapy for non-responder hepatitis C patients. Clues for controversies (ANRS HC 03 BITRI).

Maynard M, Pradat P, Bailly F, Rozier F, Nemoz C, Si Ahmed SN, Adeleine P, Trépo C; French Multicenter Group. Maynard M, et al. Among authors: adeleine p. J Hepatol. 2006 Mar;44(3):484-90. doi: 10.1016/j.jhep.2005.11.038. Epub 2005 Dec 20. J Hepatol. 2006. PMID: 16426697 Clinical Trial.

8

Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse.

Vukusic S, Hutchinson M, Hours M, Moreau T, Cortinovis-Tourniaire P, Adeleine P, Confavreux C; Pregnancy In Multiple Sclerosis Group. Vukusic S, et al. Among authors: adeleine p. Brain. 2004 Jun;127(Pt 6):1353-60. doi: 10.1093/brain/awh152. Epub 2004 May 6. Brain. 2004. PMID: 15130950

9

Predictive value of sensory and cognitive evoked potentials for awakening from coma.

Fischer C, Luauté J, Adeleine P, Morlet D. Fischer C, et al. Among authors: adeleine p. Neurology. 2004 Aug 24;63(4):669-73. doi: 10.1212/01.wnl.0000134670.10384.e2. Neurology. 2004. PMID: 15326240

10

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.

Confavreux C, Vukusic S, Adeleine P. Confavreux C, et al. Among authors: adeleine p. Brain. 2003 Apr;126(Pt 4):770-82. doi: 10.1093/brain/awg081. Brain. 2003. PMID: 12615637

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results